Systemic Administration of Interleukin-10 Attenuates Early Ischemic Response Following Spinal Cord Ischemia Reperfusion Injury in Rats

Journal of Surgical Research

Volumn 155, Issue 2, 2009, Pages 345-356

  Oruckaptan, H Hakan ^a   Ozisik, Pinar ^a   Atilla, Pergin ^a   Tuncel, Muruvet ^a   Kilinc, Kamer ^a   Geyik, Pinar Ozdemir ^a   Basaran, Nursen ^a   Yüksel, Eser ^b   Ozcan, O Ekin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

central nervous system; cytokine; inflammation; interleukin 1 ; interleukin 10; ischemia; lipid peroxidation; myeloperoxidase; reperfusion injury; spinal cord

Indexed keywords

DNA; I 3767; INTERLEUKIN 10; INTERLEUKIN 1BETA ANTIBODY; MYELOPEROXIDASE; RDI 4019; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA OCCLUSION; BALLOON OCCLUSION; CELL DAMAGE; CELL INFILTRATION; COMET ASSAY; CONTROLLED STUDY; DNA FRAGMENTATION; DNA STRAND; DRUG EFFECT; ELECTROPHORESIS; ENZYME ACTIVITY; FEMALE; GLIA; HISTOPATHOLOGY; HYPOVOLEMIA; LEUKOCYTE; LIPID PEROXIDATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; REVIEW; SPINAL CORD ISCHEMIA; TISSUE INJURY; TISSUE PRESERVATION; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY;

ANIMALS; DNA FRAGMENTATION; ENDOTHELIUM; FEMALE; INTERLEUKIN-10; INTERLEUKIN-1BETA; LIPID PEROXIDATION; MALONDIALDEHYDE; NEURONS; PEROXIDASE; RATS; RATS, MUTANT STRAINS; REPERFUSION INJURY; SPINAL CORD ISCHEMIA; TREATMENT OUTCOME;

EID: 67650935050     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.07.013     Document Type: Review

References (63)

1. Clark R.K., Lee E.V., White R.F., et al. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull 35 (1994) 387
2. Fleming J.C., Norenberg M.D., Ramsay D.A., et al. The cellular inflammatory response in human spinal cords after injury. Brain 129 (2006) 3249
3. Jean W.C., Spellman S.R., Nussbaum E.S., et al. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. Neurosurgery 43 (1998) 138225
4. Kochanek P.M., and Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23 (1992) 1367
5. Matsuo Y., Onodera H., Shiga Y., et al. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in rat: Effects of neutrophil depletion. Stroke 25 (1994) 1469
6. Barone F.C., and Feuerstein G.Z. Inflammatory mediators and stroke: New opportunities for novel therapeutics. J Cereb Blood Flow Metab 19 (1999) 819
7. Schöning B., Elepfandt P., Lanksch W.R., et al. Continuous infusion of proinflammatory cytokines into the brain to study brain cytokine induced local and systemic immune effects. Brain Res Prot 4 (1999) 217
8. Seekamp A., Jochum M., Ziegler M., et al. Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. J Trauma 44 (1998) 874
9. Schielke G.P., Yang G.Y., Shivers B.D., et al. Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice. J Cereb Blood Flow Metab 18 (1998) 180
10. Yang G.-Y., Liu X.-H., Kadoya C., et al. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector o induce overexpression of interleukin-1 receptor antagonist. J Cereb Blood Flow Metab 18 (1998) 840
11. Wang C.X., and Shuaib A. Involvement of inflammatory cytokines in the central nervous system injury. Progress Neurobiol 67 (2002) 161
12. Griffin W.S.T., Sheng J.G., Gentleman S.M., et al. Microglial interleukin -1α expression in human head injury: Correlation with neuronal and neuritic β-amyloid precursor protein expression. Neurosci Lett 176 (1994) 133
13. Hu Z.Y., Wong S.C., He Y.Y., et al. Expression of IL-1β, TNF, and IL-6 mRNAs in the ischemic cerebral cortex. Soc Neurosci Abstr 20 (1994) 615
14. Liao S.-L., and Chen C.-J. Differential effects of cytokines and redox potential on glutamate uptake in rat cortical glial cultures. Neurosci Lett 299 (2001) 113
15. Lopez-Neblina, Toledo-Pereyra L.H., Toledo A.H., et al. Ryanodine receptor antagonism protects the ischemic liver and modulates TNF-alpha and IL-10. J Surg Res 140 (2007) 121
16. Yang Z., Zingarelli B., and Szabo C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 101 (2000) 1019
17. Barbieri I., Brusa R., Basudev H., et al. Neuroprotective action of interleukin-10 in mouse primary neuronal cultures. J Neurosci Abstr 568 (1998) 13
18. Moore K.W., O'Garra A., de Wall Malefyt R., et al. Interleukin-10. Annu Rev Immunol 11 (1993) 165
19. Pousset F., Cremona S., Dantzer R., et al. Interleukin-4 and interleukin-10 regulate IL-1β induced mouse primary astrocyte activation. Glia 26 (1999) 12
20. Kanellopoulos G.K., Kato H., Hsu C.Y., et al. Spinal cord ischemic injury: Development of a new model in the rat. Stroke 28 (1997) 2532
21. Marsala M., and Yaksh T.Y. Transient spinal ischemia in the rat: characterization of behavioral and histopathological consequences as a function of the duration of aortic occlusion. J Cereb Blood Flow Metab 14 (1994) 526
22. Uchiyama M., and Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Annal Biochem 86 (1978) 271
23. Glowick S.P., and Kaplan S.D. Method in Enzymology (1995), Academic Press, New York 769-782
24. Ki{dotless}rkali{dotless} Z., Esen A.A., Hayran M., et al. The effect of extracorporeal electromagnetic shock waves on the morphology and contractility of rabbit ureter. J Urol 154 (1995) 1939
25. Anderson D., Yu T.W., Phillips B.J., et al. The effects of various antioxidants and other modifying agents on oxygen-radical generated DNA damage in human lymphocytes in the COMET assay. Mutation Res 307 (1994) 261
26. Singh N.P., McCoy M.T., Tice R.R., et al. Simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175 (1988) 184
27. Coston A., Laville M., Baud P., et al. Aortic occlusion by a balloon catheter: A method to induce hind limb rigidity in rats. Physiol Behav 30 (1983) 967
28. Abraham V.S., Swain J.A., Forgash A.J., et al. Ischemic preconditioning protects against paraplegia after transient occlusion in the rat. Ann Thorac Surg 69 (2000) 475
29. Zivin J.A., and DeGirolami U. Spinal cord infarction: A highly reproducible stroke model. Stroke 11 (1980) 200
30. Taira M., and Marsala M. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathological changes after increasing intervals of aortic occlusion in the rat. Stroke 27 (1996) 1850
31. Siesjo B.K. Calcium-mediated processes in neuronal degeneration. Ann NY Acad Sci 747 (1994) 140
32. Simpson R.K., Robertson C.S., and Goodman J.C. Spinal cord ischemia induced elevation of amino acids: Extracellular measurement with microdialysis. Neurochem Res 15 (1990) 635
33. Barone F.C., Hillegass L.M., Price W.J., et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification. J Neurosci Res 29 (1991) 336
34. Spera P.A., Ellison J.A., Feuerstein G.Z., et al. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251 (1998) 189
35. Feuerstein G.Z., Wang X., and Barone F.C. Inflammatory mediators and brain injury: The role of cytokines and chemokines in stroke and CNS disease. In: Ginsberg M.D., and Bogousslavsky J. (Eds). Cerebrovascular disease: Pathophysiology, diagnosis and management (1998), Blackwell Science, Massachusetts 507-531
36. Kelly A., Lynch A., Vereker E., et al. The anti-inflammatory cytokine, interleukin (IL)-10 blocks the inhibitory effect of IL-1β on long term potentiation. J Biol Chem 276 (2001) 45564
37. Molina-Holgado E., Vela J.M., Aravelo-Martin A., et al. LPS/INFγ cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur L Neurosci 13 (2001) 493
38. Sawada M., Suzumura A., Hosoya H., et al. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J Neurochem 72 (1999) 1466
39. Dinant S., VetelainenRL F.S., et al. IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 141 (2007) 176
40. Hayward R., Nossuli T.O., Scalia R., et al. Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion. Eur J Pharmacol 334 (1997) 157
41. Farivar A.S., Krishnadasan B., Naidu B.V., et al. Endogenous interleukin-4 and interleukin-10 regulate experimental lung ischemia reperfusion injury. Ann Thorac Surg 76 (2003) 253
42. Kaur K., Sharma A.K., and Signal P.K. Significance of changes in TNF-α and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291 (2006) 106
43. Heeschen C., Dimmeler S., Hamm C.W., et al. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109
44. Hong M., Wei W., Hu Y., et al. Plasma levels of the anti-inflammatory cytokine IL-10 and inflammatory cytokine IL-6 in patients with unstable angina. J Huazhong Univ Sci Technolog Med Sci 25 (2005) 639
45. Kremlev S.G., and Palmer C. Interleukin-10 inhibits endotoxin-induced proinflammatory cytokines in microglial cell cultures. J Neuroimmunol 162 (2005) 71
46. Agnello D., Villa P., and Ghezzi P. Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mouse. Brain Res 869 (2000) 241
47. Frenkel D., Huang Z., Maron R., et al. Neuroprotection by IL-10-producing CD4+ T cells following ischemic stroke. J Neurol Sci 233 (2005) 125
48. Holgado E.M., Vela J.M., Aravelo-Martin A., et al. LPS/INFγ cytotoxicity in oligodendroglial cells: Role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur L Neurosci 13 (2001) 493
49. Xu J., Hsu C.Y., Liu T.H., et al. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem 55 (1990) 907
50. Allan G., Bhattachherjee P., Brook C.D., et al. Myeloperoxidase activity as a quantitative marker of polymorphonuclear leukocyte accumulation into an experimental myocardial infarct: the effect of ibufen on infarct size and polymorphonuclear leukocyte accumulation. J Cardiovasc Pharmacol 7 (1985) 1154
51. Taoka Y., and Okajima K. Role of leukocytes in spinal cord injury in the rat. J Neurotrauma 17 (2000) 219
52. Bachis A., Colangelo A.M., Vicini S., et al. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 21 (2001) 3104
53. Balasingham V., and Yong V.W. Attenuation of astroglial reactivity by interleukin-10. J Neurosci 16 (1996) 2945
54. Bonmann E., Suschek C., Spranger M., et al. The dominant role of exogenous or endogenous interleukin-1β on expression and activity of inducible nitric oxide synthase in rat microvascular brain endothelial cells. Neurosci Lett 230 (1997) 109
55. Liu T., McDonnell P.C., Young P.R., et al. Interleukin-1β mRNA expression in ischemic rat cortex. Stroke 24 (1993) 1746
56. Sairanen T.R., Linsberg T.J., Brenner M., et al. Global forebrain ischemia results in differential cellular expression of interleukin-1β (IL-1β) and its receptor at mRNA and protein level. J Cereb Blood Flow Metab 17 (1997) 1107
57. Wang X.-K., Barone F.C., Aiyar N.V., et al. Increased interleukin-1 receptor and interleukin 1 receptor antagonist gene expression after focal stroke. Stroke 28 (1997) 155
58. Zhang Z., Choop M., Goussev A., et al. Cerebral vessels express interleukin-1β after focal cerebral ischemia. Brain Research 784 (1998) 210
59. Berthea J.R., Nagashima H.N., Acosta M.C., et al. Systemically administered Interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16 (1999) 851
60. Dinarello C.A. Biologic basis for interleukine-1 in disease. Blood 87 (1996) 2095
61. Lafortune L., Nalbantoglu J., and Antle J.P. Expression of tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6) mRNA in adult human astrocytes: Comparison with adult microglia and foetal astrocytes. J Neuropathol Exp Neurol 55 (1996) 515
62. Tracey K.J., and Cerami A. Tumor necrosis factor, other cytokines and disease. Ann Rev Cell Biol 9 (1993) 317
63. Mulcahy N.J., Ross J., Rothwell N.J., et al. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischemia in the rat. Br J Pharmacol 140 (2003) 471